Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study

OBJECTIVES: Dexamethasone has become the standard of care for severe coronavirus disease 2019 (COVID-19), but its virological impact is poorly understood. The objectives of this work were to characterize the kinetics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) concentration in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mühlemann, Barbara, Thibeault, Charlotte, Hillus, David, Helbig, Elisa T., Lippert, Lena J., Tober-Lau, Pinkus, Schwarz, Tatjana, Müller, Marcel A., Witzenrath, Martin, Suttorp, Norbert, Sander, Leif E., Drosten, Christian, Jones, Terry C., Corman, Victor M., Kurth, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205283/
https://www.ncbi.nlm.nih.gov/pubmed/34139335
http://dx.doi.org/10.1016/j.cmi.2021.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205283/
https://www.ncbi.nlm.nih.gov/pubmed/34139335
http://dx.doi.org/10.1016/j.cmi.2021.06.008

Ejemplares similares